DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 11.38K

Day Range

- - -

52 Wk Range

13.85 - 29.15

Market Cap

P/E Ratio

20.66

Dividend Yield

3.50%

Exchange

OTC

RSI

Short Interest

Days to Cover

316.53

Recent Daiichi Sankyo Co Ltd News

FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer

FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response rate and a $45 million milestone due.

Vandana Singh

AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients

AstraZeneca's Enhertu combo improved progression-free survival in HER2+ metastatic breast cancer in a Phase 3 trial, showing promising early results.

Vandana Singh

FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients

FDA approves Enhertu for metastatic breast cancer with HER2-low or HER2-ultralow expression after showing significant efficacy in the DESTINY-Breast06 trial.

Vandana Singh

FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients

AstraZeneca's Datroway gains FDA approval for HR-positive, HER2-negative breast cancer after prior therapies, based on Phase 3 trial data.

Vandana Singh

After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer

AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression outcomes in treated patients.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

77.66B

Investing Cash Flow (TTM)

-148.24B

Financing Cash Flow (TTM)

-97.88B

Free Cash Flow (TTM)

-71.35B

Capital Expenditure (TTM)

-149.00B

Net Change in Cash (TTM)

-168.46B

Valuation Metrics

Enterprise Value

$31.65B

PE Ratio (TTM)

20.66

PE Ratio (FWD)

21.60

PEG Ratio (TTM)

1.90

PS Ratio (TTM)

2.53

PB Ratio (TTM)

3.10

Earnings Yield % (TTM)

4.84%

Earnings Yield % (FWD)

4.63%

EV / EBITDA (TTM)

14.42

Price / EBITDA (TTM)

15.39

Price / Free Cash Flow (TTM)

Book Value / Share

$5.89

Company Debt

Total Debt

$300.48B

LT Debt

$300.08B

LT Debt Issuance (TTM)

$300.00B

LT Debt Repayment (TTM)

-$100.40B

Total Cash

$449.81B

Debt to Equity

0.29

Issuance of Debt (TTM)

$199.60B

Repayment of Debt (TTM)

-$100.40B

Key Statistics

Open

Volume / Avg.

0 / 11.38K

Day Range

- - -

52 Wk Range

13.85 - 29.15

Market Cap

P/E Ratio

20.66

Dividend Yield

3.50%

Exchange

OTC

RSI

Short Interest

Days to Cover

316.53

About

Sector

Health Care

Industry

Pharmaceuticals

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint....

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

DSKYF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

DSKYF

FAQ

How do I buy DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF) stock?

You can purchase shares of DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (OTCPK:DSKYF) through any online brokerage.

View our list of the best stock brokerages

Who are DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF) competitors?

There are no as such competitors for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd..

What is the forecast, or price target, for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF) stock?

There is no analysis for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. to provide a consensus price target.

What is the current price for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF)?

The stock price for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (OTCPK: DSKYF) is $18.2375 last updated August 24, 2026 at 2:35 PM EDT.

Does DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF) pay a dividend?

There are no upcoming dividends for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd..

When is DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (OTCPK:DSKYF) reporting earnings?

DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. does not have any upcoming earnings scheduled.

Is DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF) going to split?

There is no upcoming split for DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd..

What sector and industry does DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF) operate in?

DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.